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We report the results of a genetic screen to
identify molecules important for synapse for-
mation and/or maintenance. siRNAs were
used to decrease the expression of candidate
genes in neurons, and synapse development
was assessed. We surveyed 22 cadherin family
members and demonstrated distinct roles for
cadherin-11 and cadherin-13 in synapse devel-
opment. Our screen also revealed roles for
the class 4 Semaphorins Sema4B and Sema4D
in the development of glutamatergic and/or
GABAergic synapses. We found that Sema4D
affects the formation of GABAergic, but not
glutamatergic, synapses. Our screen also iden-
tified the activity-regulated small GTPase
Rem2 as a regulator of synapse development.
A known calcium channel modulator, Rem2
may function as part of a homeostatic mecha-
nism that controls synapse number. These
experiments establish the feasibility of RNAi
screens to characterize the mechanisms that
control mammalian neuronal development
and to identify components of the genetic pro-
gram that regulate synapse formation and/or
maintenance.
INTRODUCTION
Synapses are specialized sites of cell-cell contact that
mediate the transmission and storage of information in
the brain. The majority of synapses in the central nervous
system (CNS) are chemical synapses, where communica-
tion occurs by the release of neurotransmitter from the
presynaptic terminal, which then acts on neurotransmitter
receptors localized at the postsynaptic terminal (Li and
Sheng, 2003). Multiple, overlapping steps are requiredfor the development of glutamatergic synapses in the
mammalian hippocampus, beginning with initial contact
between the axon and the dendrite (Ziv and Garner,
2004). After initial contact, preassembled packets of pro-
teins localize to the presynaptic compartment to form the
active zone and the synaptic vesicle release machinery
(Ziv and Garner, 2004). Simultaneously, neurotransmitter
receptors, signaling molecules, and scaffolding and struc-
tural proteins cluster at the postsynaptic site (Ziv and Gar-
ner, 2004). Finally, synapses undergo a process of refine-
ment wherein a subset of synapses are weakened and
eliminated while the remainder are strengthened and
maintained (Katz and Shatz, 1996).
Given the complex nature of synapse development, it is
not surprising that multiple proteins are involved in regu-
lating this process. Trans-synaptic ligand-receptor com-
plexes and cell adhesion molecules are attractive candi-
dates for regulating contact initiation and stabilization,
as these proteins have both adhesive and intracellular sig-
naling capabilities. Indeed, the receptor tyrosine kinase
EphB and its ligand ephrinB, the neurexin/neuroligin com-
plex, and SynCAM (Biederer et al., 2002; Scheiffele et al.,
2000; Dalva et al., 2000) have been shown to play a role in
glutamatergic synapse development. Moreover, the coor-
dination of synapse development is a global cellular pro-
cess that requires gene transcription in the nucleus (Flavell
et al., 2006; Shalizi et al., 2006) and homeostatic regula-
tion to insure that excitability remains within the appropri-
ate physiological range (Turrigiano and Nelson, 2004). Al-
though intensive study has begun to identify molecules
that regulate synapse development, it is still not known
at which step in synapse development most of these mol-
ecules function. An identification of the full complement of
molecules that are required for synapse development
would represent a major advance toward understanding
the requirement for individual molecules at specific steps
in the process.
In comparison to glutamatergic synapse development,
less is known about the development of inhibitory,
GABAergic synapses. The relatively low abundance of
GABAergic synapses on hippocampal neurons hasNeuron 53, 217–232, January 18, 2007 ª2007 Elsevier Inc. 217
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present at such synapses (Fritschy and Brunig, 2003).
Thus far, only a few proteins, such as gephyrin, a
93 kDa peripheral membrane protein, and dystrophin,
the Duchenne muscular dystrophy gene product, have
been shown to regulate GABAergic synapse development
(Fritschy and Brunig, 2003).
A remaining question in the field of synapse develop-
ment is how a neuron matches the correct postsynaptic
neurotransmitter receptors to the appropriate glutamater-
gic or GABAergic presynaptic terminal. Interestingly,
several proteins can regulate both glutamatergic and
GABAergic synapse development and/or function (Chih
et al., 2005; Elmariah et al., 2004; Graf et al., 2004; Varo-
queaux et al., 2006; Weiner et al., 2005), and consider-
able mismatching of components of glutamatergic and
GABAergic synapses occurs both in vivo and in vitro (e.g.,
the localization of GABAA receptors to glutamatergic pre-
synaptic terminals) (Anderson et al., 2004; Nusser et al.,
1998; Rao et al., 2000). Moreover, the fidelity of matching
increases as the neurons mature (Anderson et al., 2004),
suggesting that neurons may execute a general program
of synapse development that is sufficient to initiate the
assembly of synaptic structures and that the final specifi-
cation of the postsynaptic structure as either glutamater-
gic or GABAergic occurs at a later step in synapse devel-
opment. These observations imply that proteins likely
exist in the postsynaptic cell that regulate the sorting
and/or matching of the proper neurotransmitter receptors
with their appropriate presynaptic terminals.
To gain insight into the molecular mechanisms that con-
trol synapse development, we developed a strategy for
discovering molecules required for the various steps in
glutamatergic and GABAergic synapse development.
Specifically, we established an RNA interference (RNAi)-
based, forward genetic screen to identify molecules that
regulate synapse development. Thus far, we have identi-
fied five genes that play a role in glutamatergic and/or
GABAergic synapse development. These include: two
cadherin family members, cadherin-11 and cadherin-13;
two class 4 Semaphorins, Sema4B and Sema4D; and the
activity-regulated small GTPase Rem2.
RESULTS
Establishment of an RNAi Screen for Synapse
Development in Mammalian Neurons
We took a two-step approach to identify molecules that
are important for the development of glutamatergic syn-
apses in hippocampal neurons. First, we used transcrip-
tional profiling to identify transcripts that are up- or down-
regulated during the time period of synapse development
in the postnatal rodent hippocampus. We also identified
genes regulated by activity in cultured neurons, as neuro-
nal activity has been shown to be required for synapse
stabilization and maintenance (Katz and Shatz, 1996).
From an analysis of the regulation of over 30,000 genes,
we compiled a list of approximately 600 genes that we218 Neuron 53, 217–232, January 18, 2007 ª2007 Elsevier Inc.considered good candidates for regulating synapse de-
velopment. From this list, we prioritized the genes to be
targeted in the RNAi screen by choosing those that were
highly induced by activity or those with relevant functional
motifs such as cadherin repeats or Ig or RING finger do-
mains (see Table S1 in the Supplemental Data). We also
supplemented our list with genes that we hypothesized
might be involved in synapse development based on
work in other organisms or on the genes’ roles in related
biological processes.
Next, to determine whether these candidate genes play
a role in synapse development, we established an RNAi-
based screen in cultured hippocampal neurons (Figure 1).
RNAi is an innate mechanism in eukaryotes in which dou-
ble-stranded 21- to 23-nucleotide small interfering RNAs
(siRNAs) target the corresponding mRNA for degradation
in a sequence-specific manner (Novina and Sharp, 2004).
We used the RNase III-family member enzyme Dicer to
construct a library of siRNAs targeting the candidate
gene products. The mixture of siRNAs produced by Dicer
digestion has been shown to effectively target specific
genes (Myers et al., 2003) (see Figures S1 and S2 in the
Supplemental Data), and in pilot experiments, we demon-
strated efficient and specific knockdown of over 15 gene
products in heterologous cells using diced siRNAs (Fig-
ure S2 and A.E. West, A. Brunet, S.P. and M.E.G., unpub-
lished data).
Before commencing the screen, diced siRNAs were
evaluated for their ability to knock down neuronally ex-
pressed proteins over the time period of synapse develop-
ment in hippocampal culture. As synapse development in
culture occurs over a period of approximately 2 weeks
(Rao et al., 1998), the time frame of gene knockdown
that is required in a screen for genes important for synapse
development is significantly longer than that required for
previously reported screens. We transfected hippocampal
neurons with diced siRNAs targeting the PSD-95 or GluR2
mRNA at 4DIV and assessed protein knockdown by quan-
titative immunocytochemistry at 14DIV. Diced siRNAs tar-
geting the PSD-95 or GluR2 mRNA significantly reduced
the expression of the targeted gene (Figure S1). In addi-
tion, we sought to increase the throughput of the screen
by transfecting pools of diced siRNAs that target multiple
genes into neurons. We found that transfecting pools of
siRNAs that target more than one gene results in knock-
down comparable to that observed with transfection of
siRNAs targeting each gene individually (Figure S3), and
thus, the majority of the screen was performed using pools
of diced siRNAs targeting multiple genes.
The assay that we established to assess the effect of
knockdown of the targeted genes on the density of gluta-
matergic synapses is as follows. We cotransfected neu-
rons with GFP and diced siRNAs at 4DIV, then fixed and
stained the transfected cells at 14DIV with antibodies
that recognize synapsin I, a synaptic vesicle-associated
protein, and PSD-95, a scaffolding protein that is highly
enriched at the postsynaptic side of glutamatergic synap-
ses. Images of transfected neurons were acquired by
Neuron
Molecules Regulating Synapse DevelopmentFigure 1. Overview of RNAi Screen
Cells were stained for PSD-95 (red) and synap-
sin I (blue), and glutamatergic synapse density
was quantified as the overlap of PSD-95/syn-
apsin I with GFP (neuronal cell bodies were ex-
cluded from all analyses of cultured neurons;
see Experimental Procedures). The white box
indicates the region of dendrite magnified at
the bottom.confocal microscopy, and synapse density was quantified
as the number of opposing synapsin I/PSD-95 puncta
present along the dendrites of GFP-expressing neurons
(see Experimental Procedures). Thus, since we scored
the number of synapses formed onto the transfected neu-
ron rather than the number of synapses formed by the
transfected neuron, we assayed the function of the tar-
geted genes in the postsynaptic neuron.
Our screen was controlled for nonspecific or ‘‘off-tar-
get’’ effects of the RNAi methodology. For one, the low
hit rate of the screen (16% of pools were initially ‘‘posi-
tive,’’ 4% were reproducibly positive) speaks to the overall
immutability of glutamatergic synapse density after trans-
fection with siRNAs (Figure 2A). Moreover, we compared
neurons transfected with GFP with neurons transfected
with GFP and siRNAs targeting DsRed and found that syn-
apse density did not differ between the two conditions
(data not shown). We also used Sholl analysis to assess
the complexity of the dendritic arbors in the diced
siRNA-treated cells and found no change as a result of
treating neurons with diced siRNAs targeting DsRed or
the genes comprising the positive pools (Figure S4). This
suggests that transfection with siRNAs did not a priori
cause a deficit in cell health or dendritic complexity and
that the reductions in glutamatergic synapse density ob-
served for our positive pools are likely not a result of a per-
turbation of cell health or dendritic complexity.Thus far, we have analyzed 160 genes comprising 105
unique pools of diced siRNAs targeting 1–4 genes
(Figure 2A and Table S1). A pool was considered positive
if the pool of diced siRNAs caused a change in the density
of glutamatergic synapses as compared with control (sig-
nificance determined by two-sample t test using a cutoff
of p < 0.05; black diamonds in Figure 2A). All positive
pools were retested and analyzed further if the pool was
positive in the second experiment (red circles in
Figure 2A). Of the 105 pools analyzed to date, 4 pools of
diced siRNAs yielded a reproducible change in synapse
density: Lin7c/Rem2, cadherin-11/cadherin-13, APC5/
Ube2d3, and Sema4A/Sema4B/Sema4D (Figures 2B
and 2C).
Deconvolution of Positive Pools
We further characterized the hits in our screen by trans-
fecting neurons with short-hairpin RNAs (shRNAs) target-
ing each of the genes from the positive pools. We thus
sought to determine which gene(s) was responsible for
the observed decrease in synapse density. We designed
three shRNAs against each of the genes in the positive
pools using current algorithms for the rational design of
shRNAs (see Experimental Procedures). Each shRNA
matches a single 21 base pair (bp) sequence within the
targeted gene. This is in contrast to the diced siRNAs
where multiple 21 bp siRNAs target the gene of interest.Neuron 53, 217–232, January 18, 2007 ª2007 Elsevier Inc. 219
Neuron
Molecules Regulating Synapse DevelopmentFigure 2. RNAi Screen Results
(A) Scatter plot of normalized glutamatergic synapse densities for neurons transfected with diced siRNAs targeting 160 different genes comprising
105 unique pools versus p value (two-sample t test). Gray diamonds, pools not positive by t test; black diamonds, pools initially positive by t test that
did not repeat as positive; red circles, pools initially positive by t test that repeated as positive. The dashed line at p = 0.05 indicates cutoff for statistical
significance.
(B) Immunostaining for PSD-95 (red) and synapsin I (blue) in the dendrites of cells cotransfected with GFP and diced siRNAs targeting the gene prod-
ucts indicated on the left. Glutamatergic synapses were defined as the overlap of red and blue puncta on a green neuron (white puncta in left panels).
The right panels display PSD-95 and synapsin I staining in the absence of the GFP signal; overlapping puncta appear magenta.
(C) Quantification of the density of PSD-95/synapsin I puncta for neurons transfected with diced siRNAs targeting the indicated gene products. n = 72
for Lin7c/Rem2, n = 69 for cadherin-11/cadherin-13, n = 77 for APC5/Ube2d3, n = 43 for Sema4A/Sema4B/Sema4D. Significance of p < 0.002 by
multifactorial ANOVA is indicated by asterisk. Error bars are ± standard error of the average ratio. The error for the control condition is contained within
the error bar for each experimental condition (see Experimental Procedures). For this and all subsequent figures, the normalized values shown are the
average of at least three independent experiments, and ‘‘n’’ refers to number of cells analyzed unless otherwise indicated. Scale bar, 5 mm.To insure maximum efficiency of knockdown by shRNAs,
we simultaneously transfected three shRNAs targeting
a specific gene into neurons and assessed synapse den-
sity. We also confirmed the specificity of the diced siRNAs
and the shRNAs for knockdown of individual gene prod-
ucts in heterologous cells (Figure S2).
By targeting each gene product from our positive pools
using shRNAs, we found that knockdown of the Rem2,
cadherin-11, cadherin-13, or Sema4B gene product
causes a decrease in the density of glutamatergic synap-
ses. The transfection of shRNAs targeting APC5 or
Sema4D has no effect on glutamatergic synapse density220 Neuron 53, 217–232, January 18, 2007 ª2007 Elsevier Inc(Figures 3A and 3B), and shRNA constructs targeting the
Sema4A and Ube2d3 gene products cause cell lethality.
Our screen identified regulators of synapse develop-
ment from multiple categories on our original list of candi-
date genes, including activity-regulated genes, cell adhe-
sion molecules, and putative pathfinding molecules,
which underscores the complex nature of synapse devel-
opment. We have investigated the importance of these
genes for glutamatergic synapse development as follows:
(1) analysis of the specificity of the RNAi phenotype
(Figures 3C, 3D, 6C, and 6D), (2) assessment of glutama-
tergic synapse development by whole-cell voltage-clamp.
Neuron
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and immunostaining with antibodies recognizing the
GluR2 subunit of the AMPAR (Figure 5), and (3) assess-
ment of the development of pre- and postsynaptic spe-
cializations independent of a requirement for colocaliza-
tion (Figures 3E and 3F). In addition, we sought to
determine if the genes identified in the screen are general
regulators of synapse development by testing whether
they are also involved in GABAergic synapse development
(Figure 6).
Cadherin-13 and Cadherin-11 Act via Distinct
Mechanisms to Regulate Synapse Development
Our screen revealed a role for the cadherin-13 and cad-
herin-11 gene products as positive regulators of glutama-
tergic synapse development. The large size of the cad-
herin family, the restricted expression of cadherin family
members, and the localization of cadherin family mem-
bers to synapses has suggested a role for the cadherin
family in determining synapse specificity (Fannon and
Colman, 1996). It is not known which cadherin family
members are important for the development of connec-
tions between specific subpopulations of neurons.
However, cadherin-11 is known to be expressed in the
hippocampus during the postnatal period when robust
synaptogenesis occurs (Manabe et al., 2000), and the
expression of cadherin-13 is upregulated between 2 and
7 days in culture, a time when synapse development is
beginning (data not shown). We further characterized the
role of cadherin-13 in synapse development and com-
pared the function of cadherin-13 to that of cadherin-11.
We began by verifying the specificity of the cadherin-13
RNAi phenotype (Figures 3C and 3D). We demonstrated
that transfection of a single shRNA construct targeting
cadherin-13, shRNA_2_Cdh13 (Figure 3C), produces a
decrease in synapse density comparable to that observed
in neurons transfected with pools of diced siRNAs (Fig-
ure 2C) or with three shRNA constructs (Figure 3B). These
various cadherin-13 RNAi technologies target distinct
regions of the cadherin-13 mRNA, and each causes a de-
crease in glutamatergic synapse density. This suggests
that the observed decreases in synapse density are due
to knockdown of the cadherin-13 mRNA and not to an
off-target effect of the RNAi.
We created a cadherin-13 expression plasmid resistant
to knockdown by shRNA_2_Cdh13 (Figure S2B) and
tested its ability to rescue the decrease in synapse density
observed with shRNA_2_Cdh13. The expression of this
plasmid by itself does not affect synapse density
(Figure 3D). When we cotransfected the RNAi-resistant
cadherin-13 expression plasmid with shRNA_2_Cdh13,
we found that expression of RNAi-resistant cadherin-13
was sufficient to rescue the decrease in synapse density
observed with transfection of shRNA_2_Cdh13 (Fig-
ure 3D). These results suggest that the decrease in syn-
apse density in cadherin-13 RNAi-treated neurons is due
to specific knockdown of the cadherin-13 gene product by
the RNAi constructs. Validation of a role for cadherin-11 inglutamatergic synapse development by rescue was com-
plicated by the fact that overexpression of cadherin-11
causes an increase in the density of glutamatergic synap-
ses (Figures 7B and 7C). Nevertheless, the observation
that the overexpression of cadherin-11 increases gluta-
matergic synapse density provides additional evidence
of a role for cadherin-11 in synapse development (see
below).
Our initial analyses utilized synapsin I/PSD-95 colocali-
zation as a measure of synapse density. The observed
decreases in synapse density could reflect a bona fide de-
crease in glutamatergic synapse number or, alternatively,
a downregulation or mislocalization of specific synaptic
proteins such as synapsin I or PSD-95. To distinguish be-
tween these possibilities, we examined the number of
AMPA receptor-containing synapses in neurons trans-
fected with shRNAs targeting the cadherin-13 or cad-
herin-11 gene product. We used whole-cell voltage-clamp
recordings in the presence of tetrodotoxin and bicuculline
to measure the frequency and amplitude of AMPA recep-
tor-mediated mEPSC events. We transfected cells with
shRNA constructs targeting cadherin-13 or cadherin-11
at 4DIV and performed whole-cell voltage-clamp record-
ings at 14DIV–15DIV. We found a significant decrease in
the frequency of mEPSCs in neurons transfected with
shRNAs targeting the cadherin-13 or cadherin-11 gene
product (Figures 4A and 4B). In addition, we detected
a small, but significant, decrease in the amplitude of
mEPSCs in the cadherin-13 and cadherin-11 shRNA-
transfected cells (Figures 4A, 4C, and 4D). By contrast,
transfection of shRNAs targeting another gene product,
Sema4D, had no effect on mEPSC frequency or amplitude
(Figure 4). We also found that neurons transfected with
shRNA constructs targeting cadherin-11, but not cad-
herin-13, had increased input resistance (Table S2), possi-
bly due to a decrease in cell soma size (data not shown).
However, this data does not confound our analysis of
mEPSC frequency, as increased input resistance should
enhance our ability to detect mEPSC events.
We also determined the density of AMPA receptor-
containing synapses by immunocytochemistry. Trans-
fected neurons were stained with antibodies that
recognize the synaptic vesicle-associated protein Synap-
totagmin I and the GluR2 subunit of the AMPA receptor,
and synapse density was quantified as the overlap of
Synaptotagmin I and GluR2 puncta on the dendrites of
transfected neurons. Neurons transfected with shRNA
constructs targeting cadherin-13 or cadherin-11, but not
Sema4D, show a significant decrease in the density of
AMPA receptor-containing synapses (Figure 5), suggest-
ing that the observed decrease in mEPSC frequency in
cadherin-13 or cadherin-11 shRNA-transfected neurons
is due, at least in part, to a decrease in the number of
functional, AMPA receptor-containing synapses.
We sought to better understand the mechanism of
action of cadherin-13 and cadherin-11 by determining
whether they are required for the development of the
pre- and/or postsynaptic specialization. For example, ifNeuron 53, 217–232, January 18, 2007 ª2007 Elsevier Inc. 221
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Molecules Regulating Synapse DevelopmentFigure 3. Deconvolution of Positive Pools Demonstrates that Rem2, Cadherin-11, Cadherin-13, and Sema4B Are Required for
Glutamatergic Synapse Development
(A) Immunostaining for PSD-95 (red) and synapsin I (blue) in the dendrites of cells cotransfected with GFP and shRNAs targeting the indicated gene
products. Glutamatergic synapses were defined as the overlap of red and blue puncta on a green neuron (white puncta in left panels). The right panels
display PSD-95 and synapsin I staining in the absence of the GFP signal; overlapping puncta appear magenta. Scale bar, 5 mm.
(B) Quantification of the density of PSD-95/synapsin I puncta for neurons transfected with three shRNA constructs targeting the indicated gene
products. n = 38 for Rem2, n = 44 for cadherin-11, n = 43 for cadherin-13, n = 46 for Sema4B, n = 44 for Sema4D, n = 39 for APC5. Significance
of p < 0.0001 by multifactorial ANOVA is indicated by asterisk.
(C) Quantification of the density of PSD-95/synapsin I puncta for neurons transfected with individual shRNA constructs targeting the cadherin-13 gene
product. n = 92 for shRNA_2_Cdh13, n = 56 for shRNA_3_Cdh13. Significance of p < 0.0001 by multifactorial ANOVA is indicated by asterisk.
(D) Quantification of the density of PSD-95/synapsin I puncta for neurons transfected with a shRNA construct targeting the cadherin-13 gene product
(shRNA_2_Cdh13), a cadherin-13 cDNA construct resistant to RNAi by shRNA_2_Cdh13 (Cadherin-13), or shRNA_2_Cdh13 and the RNAi-resistant
cadherin-13 construct (rescue). n = 54 for shRNA_2_Cdh13, n = 41 for Cadherin-13, n = 60 for rescue. Significance of p < 0.05 by multifactorial ANOVA
is indicated by asterisk; p = 0.6 for cadherin-13 versus rescue.
(E) Quantification of the density of synapsin I puncta on neurons transfected with shRNA constructs targeting the indicated gene products. n = 38 for
Rem2, n = 44 for cadherin-11, n = 43 for cadherin-13, n = 46 for Sema4B, n = 44 for Sema4D. Significance of p < 0.03 by multifactorial ANOVA is
indicated by asterisk.
(F) Quantification of the density of PSD-95 puncta in neurons transfected with shRNA constructs targeting the indicated gene products. n = 38 for
Rem2, n = 44 for cadherin-11, n = 43 for cadherin-13, n = 46 for Sema4B, n = 44 for Sema4D. Significance of p < 0.0001 by multifactorial ANOVA
is indicated by asterisk; p = 0.08 for cadherin-11.222 Neuron 53, 217–232, January 18, 2007 ª2007 Elsevier Inc.
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Molecules Regulating Synapse DevelopmentFigure 4. Rem2, Cadherin-11, Cadherin-13, and Sema4B Are Required for the Development of Functional Glutamatergic Synapses
(A) Sample traces of mEPSCs from neurons transfected with shRNAs targeting the indicated gene products.
(B) Quantification of average mEPSC frequency for neurons transfected with shRNA constructs targeting the indicated gene products. n = 15 for
Rem2, n = 15 for cadherin-11, n = 14 for cadherin-13, n = 15 for Sema4B, n = 13 for Sema4D. Significance of p < 0.05 by two-sample t test indicated
by asterisk.
(C) Quantification of average mEPSC amplitude for neurons transfected with shRNA constructs targeting the indicated gene products. n = 15 for
Rem2, n = 15 for cadherin-11, n = 14 for cadherin-13, n = 15 for Sema4B, n = 13 for Sema4D. Significance of p < 0.05 by two-sample t test indicated
by asterisk.
(D) Cumulative probability distributions of mEPSC amplitudes for neurons transfected with shRNA constructs targeting the indicated gene products.
n = 16 for control, n = 15 for Rem2, n = 15 for cadherin-11, n = 14 for cadherin-13, n = 14 for Sema4B, n = 12 for Sema4D. The cadherin-11 and
cadherin-13 mEPSC amplitude distributions are different from control by Kolmogorov-Smirnov test, p < 0.05.
Error bars are ± standard error of the average ratio. The error for the control condition is contained within the error bar for each experimental condition
(see Experimental Procedures).cadherin-13 or cadherin-11 regulates synapse develop-
ment via a homophilic adhesion event that stabilizes
contact between the axon and the dendrite, cadherinknockdown might be predicted to block multiple steps of
synapse development, leading to a decrease in the num-
ber of both pre- and postsynaptic structures. Alternatively,Error bars are ± standard error of the average ratio. The error for the control condition is contained within the error bar for each experimental condition
(see Experimental Procedures).Neuron 53, 217–232, January 18, 2007 ª2007 Elsevier Inc. 223
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Molecules Regulating Synapse DevelopmentFigure 5. Rem2,Cadherin-11,Cadherin-13, andSema4BAreRequired for theDevelopmentofAMPAReceptor-ContainingSynapses
(A) Immunostaining for GluR2 (red) and Synaptotagmin I (blue) in the dendrites of cells cotransfected with GFP and shRNAs targeting the indicated
gene products. Glutamatergic synapses were defined as the overlap of red and blue puncta on a green neuron (white puncta in left panels). The right
panels display GluR2 and Synaptotagmin I staining in the absence of the GFP signal; overlapping puncta appear magenta. Scale bar, 5 mm.
(B) Quantification of the density of GluR2/Synaptotagmin I puncta for neurons transfected with shRNA constructs targeting the indicated gene prod-
ucts. n = 45 for Rem2, n = 36 for cadherin-11, n = 54 for cadherin-13, n = 50 for Sema4B, n = 50 for Sema4D. Significance of p < 0.04 by multifactorial
ANOVA is indicated by asterisk. Error bars are ± standard error of the average ratio. The error for the control condition is contained within the error bar
for each experimental condition (see Experimental Procedures).if cadherin-13 or cadherin-11 functions exclusively to reg-
ulate the localization of molecules to the postsynaptic
density, cadherin RNAi might be predicted to cause a re-
duction in the number of postsynaptic, but not presynap-
tic, structures.
To address this question, we quantified the density of
synapsin I or PSD-95 puncta using the same confocal im-
ages that were used for assessing synapse density as the
overlap of synapsin I/PSD-95. We found that knockdown
of cadherin-13 results in a significant decrease in the den-
sity of both synapsin I and PSD-95 puncta (Figures 3E and
3F), suggesting that cadherin-13 acts at an early step in
synapse development required for the formation or stabi-
lization of both the pre- and postsynaptic specialization.
Knockdown of cadherin-11 causes a small, but signifi-
cant, decrease in the density of synapsin I puncta and
a trend toward a decrease in the density of PSD-95 puncta
(p = 0.08; Figures 3E and 3F), suggesting that cadherin-11
may be required for a trans-synaptic signaling event that
preferentially initiates presynaptic assembly.
We next asked if cadherin-13 or cadherin-11 is also re-
quired for GABAergic synapse development. We trans-
fected neurons with GFP and shRNAs targeting the cad-
herin-13 or cadherin-11 gene products at 4DIV, and at
14DIV, we stained the cells with antibodies that recognize
the presynaptic vesicular GABA transporter VGAT and the
b2/3 subunit of the GABAA receptor. We quantified the
number of overlapping VGAT and GABAA receptor puncta
on the transfected neurons and found that RNAi of cad-
herin-13 or cadherin-11 causes a decrease in the density
of GABAergic synapses (Figures 6A and 6B). In contrast,
shRNA constructs targeting another gene product,
APC5, had no effect on GABAergic synapse density (Fig-
ures 6A and 6B). We also assessed GABAergic synapse224 Neuron 53, 217–232, January 18, 2007 ª2007 Elsevier Incdensity using antibodies recognizing the presynaptic
GABA-synthesizing enzyme GAD67 and the g2 subunit
of the GABAA receptor and found that GABAergic synapse
density was significantly decreased in neurons trans-
fected with shRNAs targeting cadherin-13 or cadherin-
11 (data not shown). These results indicate that cad-
herin-13 and cadherin-11 regulate both glutamatergic
and GABAergic synapse development, possibly at
a step common to the development of both types of
synapses.
To gain further insight into the function of cadherin-13
and cadherin-11, we examined the subcellular localization
of N-terminal myc-tagged cadherin-13 and cadherin-11 in
cultured hippocampal neurons (Figure 7A). Cadherin-13 is
unique among the cadherin family in that it is linked to the
cell membrane via a glycosylphosphatidylinositol (GPI)
moiety, whereas cadherin-11 is a type II transmembrane
domain-containing cadherin (Nollet et al., 2000). We ob-
served myc-cadherin-13 immunoreactivity in discrete
puncta within and next to the transfected dendrite, while
myc-cadherin-11 seemed to be contained within the den-
dritic shaft (Figure 7A). Although the localization of the
overexpressed protein may not precisely reflect the local-
ization of the endogenous protein, these results suggest
that cadherin-13 and cadherin-11 may have different
mechanisms of action. For example, cadherin-13, in con-
trast to cadherin-11, may be cleaved from the cell surface,
and its release from the membrane may have functional
consequences for its role in synapse development (Baron
and Caughey, 2003).
To better understand the role of cadherin-13 and cad-
herin-11 in synapse development, we also asked if either
protein is able to promote synapse development when
overexpressed in neurons. We analyzed the density of.
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of neurons transfected with plasmids expressing the myc-
cadherin-13 or myc-cadherin-11 proteins. We found that
ectopic expression of cadherin-11, but not cadherin-13,
was sufficient to increase synapse number (Figure 7B
and 7C). This is in contrast to previous work that demon-
strated that the overexpression of N-cadherin, a related
cadherin family member, is not sufficient to increase
synapse number (Graf et al., 2004; Scheiffele et al.,
2000; Togashi et al., 2002).
Class 4 Semaphorin Family Members Regulate both
Glutamatergic and GABAergic Synapse
Development
In addition to cadherin family members, our screen identi-
fied a role for Sema4B in glutamatergic synapse develop-
ment (Figures 2 and 3). Having established that RNAi
knockdown of Sema4B causes a decrease in the density
of synapsin I/PSD-95 colocalized puncta (Figures 2 and
3), we asked if RNAi of Sema4B also affects the frequency
and amplitude of AMPA receptor-mediated mEPSCs and/
or the density of AMPA receptor-containing synapses. We
found that neurons transfected with RNAi constructs tar-
geting Sema4B exhibit a decrease in the frequency and
amplitude of AMPA receptor-mediated mEPSCs (Fig-
ure 4). In addition, we found that the density of AMPA re-
ceptor-containing synapses was decreased in neurons
transfected with RNAi constructs targeting Sema4B and
stained for Synaptotagmin I and GluR2 (Figure 5). Thus,
by three independent assays, we have identified a role
for Sema4B in glutamatergic synapse development.
We asked whether Sema4B is required for the develop-
ment of the pre- and/or postsynaptic specialization. We
found that knockdown of Sema4B causes a decrease in
the density of PSD-95, but not synapsin I, puncta (Figures
3E and 3F), suggesting that Sema4B is preferentially re-
quired for development of the postsynaptic specialization.
This result is intriguing, as Sema4B has been shown to
bind to the postsynaptic scaffolding protein PSD-95 via
a C-terminal PDZ binding motif and to localize to PSD-
95-containing synapses in cultured hippocampal neurons
(Burkhardt et al., 2005). Indeed, we find that an N-terminal
myc-tagged Sema4B protein is widely expressed
throughout the neuron and is present at glutamatergic
synapses (Figure S5), consistent with a role for Sema4B
in regulating the maturation of the postsynaptic density
once synapse formation has begun.
In addition, we asked if Sema4B functions specifically to
regulate glutamatergic synapse development or if it also
regulates GABAergic synapse development. We assayed
the density of GABAergic synapses on neurons trans-
fected with shRNAs targeting Sema4B and found that
knockdown of Sema4B causes a decrease in GABAergic
synapse density (Figures 6A and 6B). We found that
RNAi of Sema4B significantly affects the density of GABAA
receptor puncta while having a less dramatic effect on the
density of VGAT puncta (Figures 6E and 6F). This is similar
to the effect of knockdown of Sema4B on glutamatergicNsynapse development, where the postsynaptic specializa-
tion is principally disrupted (Figures 3E and 3F). Taken to-
gether, these findings suggest that Sema4B may play
a role in assembling the postsynaptic specialization at
both glutamatergic and GABAergic synapses.
During our analysis of Sema4B, we used RNAi con-
structs targeting the related Semaphorin Sema4D as
a negative control. Knockdown of Sema4D had no effect
on glutamatergic synapses as assessed by the colocaliza-
tion of synapsin I/PSD-95 and Synaptotagmin I/GluR2
or by the recording of AMPA receptor-mediated mEPSCs
(Figures 3–5). Quite unexpectedly, we found that knock-
down of Sema4D leads to a significant decrease in
GABAergic synapse density as assessed by the colocali-
zation of GAD65/GABAAb2/3 receptor (Figures 6A and
6B) and GAD67/GABAAg2 receptor (data not shown and
Figures 6C and 6D). We verified the specificity of the
effect of Sema4D knockdown on GABAergic synapse
density by first demonstrating that nonoverlapping shRNA
constructs targeting Sema4D, shRNA_1_Sema4D or
shRNA_2_Sema4D, cause a decrease in synapse density
(Figures 6C and 6D). Second, we rescued the decrease in
synapse density caused by Sema4D knockdown by co-
expressing shRNA_2_Sema4D and a full-length Sema4D
construct resistant to knockdown by shRNA_2_Sema4D
(Figure S2D). Expression of RNAi-resistant Sema4D by it-
self did not affect GABAergic synapse density (Figure 6D);
however, the expression of RNAi-resistant Sema4D was
sufficient to rescue the decrease in GABAergic synapse
density observed with transfection of shRNA_2_Sema4D
(Figure 6D). Taken together, these results indicate that
the observed decrease in GABAergic synapse density is
due to specific knockdown of Sema4D by the RNAi
constructs.
We next asked whether Sema4D regulates the develop-
ment of the GABAergic pre- and/or postsynaptic special-
ization. We found that RNAi of Sema4D significantly af-
fects the density of GABAA receptor puncta while having
a less dramatic effect on the density of VGAT puncta (Fig-
ures 6E and 6F). This suggests that Sema4D exerts its
effect on GABAergic synapse development primarily via
the assembly of the postsynaptic specialization.
To gain further insight into the function of Sema4D in
GABAergic synapse development, we examined its ex-
pression pattern and subcellular localization. Results
from transcriptional profiling experiments revealed that
Sema4D transcripts are expressed in our hippocampal
cultures at the time that synapses are forming, and prelim-
inary analysis demonstrated that Sema4D mRNA is pres-
ent in the principal cell layers of the hippocampus at post-
natal day 7 (P7) (data not shown), a finding corroborated
by both the Brain Gene Expression Map and Allen Brain
Atlas (Magdaleno et al., 2006; http://www.brain-map.
org/). We also used antibody staining to examine the sub-
cellular localization of a C-terminal myc-tagged Sema4D
construct and found that myc-tagged Sema4D is ex-
pressed throughout the neuron (Figure S5B). Taken to-
gether, these data demonstrate that Sema4D is expressedeuron 53, 217–232, January 18, 2007 ª2007 Elsevier Inc. 225
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Molecules Regulating Synapse DevelopmentFigure 6. Rem2, Cadherin-11, Cadherin-13, Sema4B, and Sema4D Are Required for GABAergic Synapse Development
(A) Immunostaining for GABAAb2/3 receptor (red) and VGAT (blue) in the dendrites of cells cotransfected with GFP and shRNAs targeting the indicated
gene products. GABAergic synapses were defined as the overlap of red and blue puncta on a green neuron (white puncta in left panels). The right
panels display GABAAb2/3 receptor and VGAT staining in the absence of the GFP signal; overlapping puncta appear magenta. Scale bar, 5 mm.
(B) Quantification of the density of GABAAb2/3 receptor/VGAT puncta for neurons transfected with three shRNA constructs targeting the indicated
gene products. n = 56 for Rem2, n = 70 for cadherin-11, n = 63 for cadherin-13, n = 62 for Sema4B, n = 60 for Sema4D, n = 64 for APC5. Significance of
p < 0.03 by multifactorial ANOVA is indicated by asterisk.
(C) Quantification of the density of GABAAg2 receptor/GAD67 puncta for neurons transfected with individual shRNA constructs targeting the Sema4D
gene product. n = 58 for shRNA_1_Sema4D, n = 103 for shRNA_2_Sema4D. Significance of p < 0.005 by multifactorial ANOVA is indicated by asterisk.
(D) Quantification of the density of GABAAg2 receptor/GAD67 puncta for neurons transfected with a shRNA construct targeting the Sema4D gene
product (shRNA_2_Sema4D), a Sema4D cDNA resistant to RNAi by shRNA_2_Sema4D (Sema4D), or shRNA_2_Sema4D and the RNAi-resistant
Sema4D construct (rescue). n = 67 for shRNA_2_Sema4D, n = 44 for Sema4D, n = 54 for rescue. Significance of p < 0.02 by multifactorial ANOVA
is indicated by asterisk; p = 0.15 for Sema4D versus rescue.
(E) Quantification of the density of VGAT puncta on neurons transfected with shRNA constructs targeting the indicated gene products. n = 62 for
Sema4B, n = 60 for Sema4D. Significance of p < 0.0001 by multifactorial ANOVA is indicated by asterisk.226 Neuron 53, 217–232, January 18, 2007 ª2007 Elsevier Inc.
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Molecules Regulating Synapse DevelopmentFigure 7. Cadherin-11 and Cadherin-13 Have Distinct Subcellular Localizations in Neurons and Cadherin-11 Overexpression
Promotes Glutamatergic Synapse Development
(A) Immunostaining at 14DIV for myc (red) in the dendrites of cells cotransfected with GFP and myc-tagged cDNA constructs as indicated on the left.
Scale bar, 5 mm.
(B) Immunostaining for PSD-95 (red) and synapsin I (blue) in the dendrites of cells cotransfected with GFP and myc-tagged cDNA constructs as
indicated on the left. Glutamatergic synapses were defined as the overlap of red and blue puncta on a green neuron (white puncta in left panels).
The right panels display PSD-95 and synapsin I staining in the absence of the GFP signal; overlapping puncta appear magenta. Scale bar, 5 mm.
(C) Quantification of the density of PSD-95/synapsin I puncta for neurons transfected with a cDNA construct encoding myc-tagged Cadherin-11 or
myc-tagged Cadherin-13. n = 55 for Cadherin-11, n = 76 for Cadherin-13. Significance of p < 0.01 by multifactorial ANOVA is indicated by asterisk.
Error bars are ± standard error of the average ratio. The error for the control condition is contained within the error bar for each experimental condition
(see Experimental Procedures). ‘‘n’’ refers to number of sections.in the principal cells of the hippocampus at the time that
GABAergic synapses are forming.
We next asked if Sema4D regulates GABAergic syn-
apse development in vivo by analyzing synapse develop-
ment in a mouse carrying a targeted deletion of the
Sema4D gene (Shi et al., 2000). We immunostained coro-
nal sections from P20–P23 Sema4D/ and wild-type lit-
termates with an antibody recognizing GAD67 (Figure 8).
We imaged eight distinct regions of the hippocampus in
matched wild-type and Sema4D/ sections (see Experi-
mental Procedures) and found a modest but reproducible
decrease in the average intensity of GAD67 immunoreac-
tivity in the Sema4D/ animals compared with wild-type
animals in seven of the eight regions examined (Figure 8
and Table S3). We confirmed that the total number of cellsin the hippocampus was unchanged between Sema4D/
and wild-type animals by counting nuclei stained with the
DNA binding dye Hoechst 33342 (Table S3). This result
suggests that the decrease in GAD67 immunoreactivity
does not reflect an overall decrease in the number of cells
in the hippocampus of the Sema4D/ mice. This initial
analysis of the Sema4D/ mice is consistent with the
possibility that Sema4D functions to regulate GABAergic
synapse development in the intact nervous system.
The Intracellular Signaling Molecule Rem2
Is Required for both Glutamatergic and
GABAergic Synapse Development
In addition to the identification of four cell surface proteins
that regulate the development of glutamatergic and/or(F) Quantification of the density of GABAAb2/3 receptor puncta on neurons transfected with shRNA constructs targeting the indicated gene products.
n = 62 for Sema4B, n = 60 for Sema4D. Significance of p < 0.0001 by multifactorial ANOVA is indicated by asterisk.
Error bars are ± standard error of the average ratio. The error for the control condition is contained within the error bar for each experimental condition
(see Experimental Procedures).Neuron 53, 217–232, January 18, 2007 ª2007 Elsevier Inc. 227
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Molecules Regulating Synapse DevelopmentFigure 8. Sema4D/ Mice Have Reduced GAD67 Immunoreactivity in the Hippocampus
(A) Immunostaining for bHLHb5 (green) and GAD67 (red) in the granule cell layer of the dentate gyrus for sections from Sema4D+/+ and Sema4D/
littermates. Scale bar, 10 mm.
(B) Quantification of GAD67 staining intensity (normalized to bHLHb5 staining intensity) in the granule cell layer of the dentate gyrus for sections from
Sema4D+/+ and Sema4D/ littermates. n = 42 for both conditions. Significance of p < 0.0001 by multifactorial ANOVA is indicated by asterisk. Error
bars are ± standard error of the average ratio. The error for the control condition is contained within the error bar for each experimental condition (see
Experimental Procedures).GABAergic synapses, our RNAi screen revealed a role for
the cytoplasmic GTPase Rem2 in synapse development.
Rem2 is a member of the Rem, Rad, and Gem/Kir (RGK)
family of Ras-related small GTPases and has been shown
to regulate calcium channel function and cytoskeletal re-
arrangements (Beguin et al., 2005; Chen et al., 2005; Finlin
et al., 2005).
We found that transfection of diced siRNAs or a pool of
three shRNAs targeting Rem2 causes a decrease in the
density of synapsin I/PSD-95 puncta (Figures 2B, 2C,
3A, and 3B). Cells transfected with shRNA constructs tar-
geting Rem2 also exhibit decreases in the frequency and
amplitude of mEPSCs and in the density of AMPA recep-
tor-containing synapses (Figures 4 and 5), suggesting that
Rem2 plays a role in regulating glutamatergic synapse de-
velopment. We sought further insight into the mechanism
of action of Rem2 by asking whether it regulates the devel-
opment of the pre- and/or postsynaptic specialization.
Knockdown of Rem2 results in a significant decrease in the
density of both synapsin I and PSD-95 puncta (Figure 3E
and 3F), suggesting that Rem2 acts at an early step in syn-
apse development before the formation or stabilization of
the pre- and postsynaptic specialization. We also asked if
Rem2 regulates GABAergic synapse development by as-
saying the density of GABAergic synapses on neurons
transfected with RNAi constructs targeting Rem2. Knock-
down of Rem2 led to a significant decrease in the density
of GABAergic synapses (Figures 6A and 6B), suggesting
that Rem2 is a general synaptogenic factor that regulates
both glutamatergic and GABAergic synapse development
and/or maturation.
We next sought to gain insight into the mechanism by
which Rem2 regulates synapse development. It has228 Neuron 53, 217–232, January 18, 2007 ª2007 Elsevier Inc.been shown that the transcription of Rem2 is regulated
by extracellular stimuli (Finlin et al., 2005), and indeed,
we find that depolarization of neurons grown for 5 days
in vitro induces the expression of Rem2 mRNA (data not
shown; confirmed by semiquantitative RT-PCR; Fig-
ure S6A). This raises the possibility that Rem2 regulates
synapse density as part of a feedback loop that controls
calcium influx into the neuron. Finally, we examined the
subcellular localization of an N-terminal myc-tagged
Rem2 construct and found that myc-tagged Rem2 is ex-
pressed throughout the axon, cell body, and dendrites of
hippocampal neurons (Figure S6B). The observation that
Rem2 is localized throughout the neuron, taken together
with the finding that Rem2 transcription is induced by
membrane depolarization, suggests that Rem2 may act
globally in response to neuronal activity to affect a neu-
ron’s ability to develop synapses.
DISCUSSION
In this study, we demonstrate the utility of an RNAi-based
screen to identify molecules required for the development
and/or maturation of synapses in the mammalian hippo-
campus. Interestingly, the molecules identified by our
screen as mediators of glutamatergic synapse develop-
ment also appear to play a role in GABAergic synapse
development, suggesting that common mechanisms reg-
ulate the development of these distinct synapse subtypes.
In contrast, we found that Sema4D regulates GABAergic,
but not glutamatergic, synapse development, making
Sema4D one of only a few proteins identified to date
that regulates the development of GABAergic, but not
glutamatergic, synapses. This finding also indicates that
Neuron
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absence of a normal density of GABAergic inputs and sug-
gests that glutamatergic and GABAergic synapse devel-
opment are, in part, controlled by distinct mechanisms.
Surprisingly, our screen did not identify proteins that
control glutamatergic synapse development without also
affecting GABAergic synapse development. A number of
molecules have been shown to be required for both gluta-
matergic and GABAergic synapse development and/or
function (Chih et al., 2005; Elmariah et al., 2004; Graf
et al., 2004; Togashi et al., 2002; Varoqueaux et al.,
2006; Weiner et al., 2005), suggesting that a core group
of proteins may mediate cellular processes that are critical
for the development of both types of synapses. For exam-
ple, synapses may form promiscuously between neurons
through the function of adhesion molecules such as cad-
herin-11, while the final identity of the postsynaptic spe-
cialization as either glutamatergic or GABAergic might
be specified only after contact between the axon and
the dendrite has been established. Alternatively, neurons
lacking glutamatergic synapses might be less likely to
form GABAergic synapses as a result of homeostatic
mechanisms which maintain excitability within an appro-
priate physiological range (Turrigiano and Nelson, 2004).
In this case, the molecules we have identified as regula-
tors of glutamatergic synapse development might be indi-
rectly involved in GABAergic synapse development.
Cadherin Family Members as Mediators of Synapse
Development
In addition to suggesting general conclusions about the
mechanisms of glutamatergic and GABAergic synapse
development, our RNAi screen has provided evidence
concerning the role of specific proteins in this process.
Of the 22 cadherin family members assayed in our screen,
only cadherin-13 and cadherin-11 were identified as play-
ing roles in synapse development. This may be due to
variability in the effectiveness of the RNAi-mediated
knockdown of the various cadherin family members. Alter-
natively, a role for additional cadherin family members in
synapse development may have been obscured by func-
tional redundancy among related family members. This
possibility is intriguing in that it suggests that cadherin-
13 and cadherin-11 play nonredundant roles in synapse
development.
It has been postulated that the expression of cadherins
by distinct subsets of neurons constitutes a ‘‘code’’ which
allows for the matching of the correct pre- and postsynap-
tic partners during synapse formation (Salinas and Price,
2005). However, to our knowledge studies to date have
failed to identify which members of this family are impor-
tant for the development of specific subsets of synapses.
We have demonstrated that the loss of cadherin-11
causes a decrease in synapse density, while the overex-
pression of cadherin-11 promotes the development of glu-
tamatergic synapses, suggesting that cadherin-11 may
initiate contact between the axon and the dendrite.
Cadherin-13 seems to function by a distinct mechanism,as it appears to be cleaved from the cell surface and,
thus far, we have not been able to demonstrate that
overexpression causes an increase in synapse density.
The data presented here advance our understanding of
the role of cadherin family members in synapse develop-
ment by demonstrating that two family members, cad-
herin-13 and cadherin-11, are important regulators of syn-
apse development that appear to function via distinct
mechanisms.
Differing Requirements for Sema4B and Sema4D
in Glutamatergic and GABAergic Synapse Formation
Based on the role of the EphB receptor tyrosine kinase in
axonal pathfinding and synapse development, we hypoth-
esized that other proteins implicated in neuronal pathfind-
ing might also regulate synapse development. We as-
sayed 41 putative membrane-bound pathfinding ligands
and receptors in our screen and revealed a role for
Sema4B and Sema4D in glutamatergic and/or GABAergic
synapse development. The Semaphorin family comprises
over 30 members grouped into eight classes on the basis
of sequence similarity and domain organization (He et al.,
2002). Of the vertebrate Semaphorins, the secreted class
3 Semaphorins have been shown to serve as repulsive
guidance cues in the nervous system; however, the role
of the membrane-bound class 4–7 Semaphorins in ner-
vous system function is poorly understood.
Our data indicates that Sema4B preferentially regulates
the development of the postsynaptic specialization at glu-
tamatergic synapses. Sema4B contains extracellular
Sema and Ig domains and a short intracellular C-terminal
domain that includes a PDZ binding motif (He et al., 2002).
PDZ domain-containing proteins function as scaffolds to
localize receptors and signaling molecules to glutamater-
gic synapses (McGee and Bredt, 2003). As such, Sema4B
may play a role in assembling the postsynaptic specializa-
tion by recruiting scaffolding proteins to the postsynaptic
density. In support of this model, Sema4B interacts with
PSD-95 and is present at glutamatergic synapses (Bur-
khardt et al., 2005). In addition to our discovery of a role
for Sema4B in synapse development, a class 3 Sema-
phorin has recently been shown to modulate synaptic
transmission in the mammalian hippocampus (Sahay
et al., 2005), and a Drosophila Semaphorin homolog has
been shown to regulate synapse formation at the Giant
Fiber synapse (Godenschwege et al., 2002). Taken
together, these findings suggest that Semaphorins may
play a general role in regulating glutamatergic synapse
development.
One of the most striking findings reported here is that
Sema4D plays a role in GABAergic synapse development.
It is possible that Sema4D functions to convert a stable,
but not yet specified, synaptic contact into a GABAergic
synapse, for example by recruitment of GABA receptors
to the postsynaptic specialization. Although Sema4D is
anchored to the cell surface via a transmembrane domain,
it has been demonstrated in the immune system that
the extracellular domain of Sema4D can be cleaved byNeuron 53, 217–232, January 18, 2007 ª2007 Elsevier Inc. 229
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et al., 2001). Thus, Sema4D may mediate its effects on
GABAergic synapse development either as a mem-
brane-bound molecule or/and in a non-cell autonomous
manner as a cleaved protein. It is also possible that
Sema4D affects GABAergic synapse development by en-
gaging a receptor such as PlexinB1 (Tamagnone et al.,
1999). Identifying the receptor that acts in concert with
Sema4D has the potential to provide further insight into
GABAergic synapse development.
The Role of Activity-Regulated Genes in Synapse
Development
The importance of neuronal activity for synaptic refine-
ment and maturation is well documented (Katz and Shatz,
1996), and a number of activity-regulated genes have
been shown to play a role in synapse formation, function,
and/or elimination (Flavell et al., 2006; Pak and Sheng,
2003; Sala et al., 2003; Shalizi et al., 2006; Steward and
Worley, 2001; West et al., 2001). To better understand
how activity-regulated genes function to control synapse
development, we asked whether the activity-regulated
genes we identified by transcriptional profiling were also
required for synapse development.
Our screen revealed a role for the activity-regulated
small GTPase Rem2 in the development of glutamatergic
and GABAergic synapses. Previous work demonstrated
a role for Rem2 in the regulation of calcium currents in
neurons (Chen et al., 2005). This observation, taken to-
gether with our finding that Rem2 regulates synapse de-
velopment, suggests that a connection may exist between
the role of Rem2 in calcium homeostasis and its role in
synapse development. In support of this hypothesis, ma-
nipulation of the activity level of the postsynaptic neuron is
known to affect the ability of the neuron to form and/or
maintain synapses (Burrone et al., 2002; Pratt et al.,
2003). Our success in identifying a role for the activity-reg-
ulated gene Rem2 in synapse development suggests that
further study of activity-regulated genes and of Rem2 will
provide new insight into how a neuron transforms mem-
brane depolarization into a change in gene expression to
regulate synapse formation and/or function.
An Approach for Gene Discovery in Mammalian
Neurons
To date, technical challenges have hindered the large-
scale identification of molecules that are required for syn-
apse development in the mammalian CNS. Thus, a large-
scale, unbiased strategy to identify new molecules that
are important for synapse formation and/or maintenance
has the potential to greatly advance our understanding
of this process. Our screen demonstrates the feasibility
of using RNAi in mammalian neurons to identify molecules
that function in CNS development. The success of our
screen suggests that further screening would yield insight
into the genetic program that regulates both glutamatergic
and GABAergic synapse development. We believe that
the current screen, with modifications to the phenotypic230 Neuron 53, 217–232, January 18, 2007 ª2007 Elsevier Incassay, could also be used for the identification of genes
required for processes such as dendritic and axonal out-
growth and activity-regulated gene transcription. The
challenge for future approaches to RNAi screening in
mammalian neurons will be to increase throughput using
technologies that enable automated assessment of com-
plex neuronal phenotypes.
EXPERIMENTAL PROCEDURES
Screen Design
Activity-regulated or developmentally regulated genes were identified
using Affymetrix arrays as described in the Supplemental Data. The
screen was conducted such that the average density of colocalized
synapsin I/PSD-95 puncta was compared between experimental and
control conditions. A pool was considered ‘‘positive’’ if it was signifi-
cantly different (p < 0.05) from control by a two-sample t test. Positive
pools were re-screened, and those that were positive by the above cri-
teria in two or more independent experiments were analyzed further.
See the Supplemental Data for further details.
RNAi Constructs
Recombinant Dicer enzyme was used to generate diced siRNAs as de-
scribed in the Supplemental Data. shRNAs expressed from the pSuper
vector targeting specific genes were generated as described in the
Supplemental Data.
Cell Culture and Transfection
E18 hippocampal neurons were grown at low density on a glial
monolayer and transfected at 4DIV by the calcium phosphate method.
For a detailed description of neuronal cell culture and transfection
conditions, see the Supplemental Data. HEK 293T cells were trans-
fected by the calcium phosphate method and protein knockdown
was assessed by western blotting as described in the Supplemental
Data.
Electrophysiology
mEPSC amplitude and frequency were measured by whole-cell volt-
age-clamp recording as described in the Supplemental Data.
Immunocytochemistry
Cultured hippocampal neurons were fixed and stained for the myc an-
tigen and various synaptic markers as described in the Supplemental
Data. Images were acquired on a Zeiss LSM510 or Zeiss LSM5 Pascal
confocal microscope and analyzed using OpenLab (Improvision) or
Metamorph (Molecular Devices) image analysis software. For a de-
tailed description of image acquisition and analysis, see the Supple-
mental Data.
Analysis of GAD67 Staining in Hippocampus
Hippocampal sections from P20–P23 wild-type and Sema4D/ litter-
mates were stained with anti-GAD67 antibody and imaged on a Zeiss
LSM5 Pascal confocal microscope. The intensity of immunoreactivity
was analyzed using Metamorph Image analysis software. For a detailed
description of the immunohistochemistry and image acquisition and
analysis, see the Supplemental Data.
Data Normalization and Statistics
For a detailed description of the statistical treatment of the data, see
the Supplemental Data.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/53/2/217/DC1/..
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